Synopsis of recent research by authors named "Shiquan Wu"
- Shiquan Wu's research emphasizes chronic kidney disease (CKD) and metabolic disorders, focusing on evaluating various indicators like the triglyceride-glucose index (TyG) and the Metabolic Score for Visceral Fat (METS-VF) as predictive tools for CKD risk in different populations, particularly in China.
- Wu investigates the role of specific biomarkers, such as high-density lipoprotein subclasses (HDL2b) and TIMP2 expression, in the context of metabolic syndrome and chronic renal allograft dysfunction, respectively, indicating their potential to serve as early indicators and therapeutic targets.
- Additionally, Wu's research spans into computational studies on the interactions of anticancer drugs with nanocages, showcasing the application of density functional theory (DFT) to understand drug behavior at the molecular level, highlighting a diverse scientific inquiry from clinical to theoretical frameworks.
